We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECL icon
101
Ecolab
ECL
$79.3B
$40.5M 0.25%
204,902
+405
+0.2% +$75.3K
MS icon
102
Morgan Stanley
MS
$340B
$40.4M 0.25%
921,206
+882,957
+2,308% +$39.4M
VMC icon
103
Vulcan Materials
VMC
$36.5B
$39.8M 0.25%
289,819
-1,147,073
-80% -$146M
ARMK icon
104
Aramark
ARMK
$14.8B
$39.7M 0.25%
1,525,903
+1,121,451
+277% +$26.2M
OPTU
105
Optimum Communications Inc
OPTU
$315M
$38.8M 0.24%
1,593,313
+127,508
+9% +$3.03M
LSXMK
106
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$38.7M 0.24%
1,336,887
+265,193
+25% +$7.76M
JD icon
107
JD.com
JD
$43.8B
$36.6M 0.23%
1,208,668
+473,244
+64% +$13.6M
LW icon
108
Lamb Weston
LW
$7.17B
$36.5M 0.23%
575,724
+381,801
+197% +$25.2M
RIO icon
109
Rio Tinto
RIO
$163B
$36.2M 0.22%
581,323
+104,978
+22% +$6.29M
LIN icon
110
Linde
LIN
$227B
$34.5M 0.21%
171,703
-132,482
-44% -$24.8M
FANG icon
111
Diamondback Energy
FANG
$52.8B
$34.3M 0.21%
314,652
+28,162
+10% +$2.94M
KHC icon
112
Kraft Heinz
KHC
$29.7B
$34M 0.21%
1,095,763
+1,051,788
+2,392% +$33.2M
BAC icon
113
Bank of America
BAC
$440B
$33.7M 0.21%
1,160,839
-854,646
-42% -$24.6M
RL icon
114
Ralph Lauren
RL
$23.7B
$33.4M 0.21%
293,626
+35,733
+14% +$4.28M
EMR icon
115
Emerson Electric
EMR
$87.2B
$32.7M 0.2%
490,411
+487,453
+16,479% +$32.7M
FIVE icon
116
Five Below
FIVE
$12.6B
$32.2M 0.2%
268,423
+254,242
+1,793% +$33.5M
LSXMA
117
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$32.2M 0.2%
1,177,253
+315,552
+37% +$8.73M
AGN
118
DELISTED
Allergan plc
AGN
$31.6M 0.2%
188,804
+185,716
+6,014% +$25.7M
LULU icon
119
lululemon athletica
LULU
$14.2B
$31.1M 0.19%
172,407
+28,433
+20% +$4.94M
STE icon
120
Steris
STE
$22.2B
$30.5M 0.19%
+204,553
New +$27.3M
ET icon
121
Energy Transfer Partners
ET
$71.1B
$30.4M 0.19%
2,160,898
+463,959
+27% +$6.87M
DLTR icon
122
Dollar Tree
DLTR
$24.8B
$30.3M 0.19%
281,964
-98,958
-26% -$10.4M
ADT icon
123
ADT
ADT
$5.63B
$30.3M 0.19%
4,943,885
-18,953
-0.4% -$121K
LYB icon
124
LyondellBasell Industries
LYB
$20B
$30.1M 0.19%
349,193
+277,884
+390% +$23.7M
RTX icon
125
RTX Corp
RTX
$300B
$29.7M 0.18%
362,244
+339,113
+1,466% +$28.4M

Similar funds

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.